FDA Adverse Event
Malfunction
Summary report: N
COAGUCHEK® XS SYSTEM
MDR report key: 1971340
·
Received January 27, 2011
Report
- Report Number
- 1823260-2011-00428
- Event Type
- Malfunction
- Date Received
- January 27, 2011
- Date of Event
- January 12, 2011
- Report Date
- March 15, 2011
- Manufacturer
- ROCHE DIAGNOSTICS
- Product Code
- GJS
- PMA / PMN Number
- K062925
- Removal / Correction Number
- NA
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- AZ, US
- Reporter Occupation
- NURSE
Narratives
Description of Event or Problem · 1
CALLER STATES THE PATIENT TESTED 2.2 INR ON THE COAGUCHEK XS SYSTEM AND 3.8 INR ON A COMPARISON LAB. NO ACTIONS WERE REPORTED TAKEN OR TREATMENT RECEIVED. NO ADVERSE EVENT REPORTED. A REQUEST WAS MADE FOR THE RETURN OF THE AFFECTED PRODUCT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | COAGUCHEK® XS SYSTEM | PROTHROMBIN TIME TEST STRIPS | GJS | ROCHE DIAGNOSTICS | NA | 20182931 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 066 YR | COLACE (DAILY)| LORAZEPAM (TWICE DAILY)| PRILOSEC (DAILY)| COUMADIN (DAILY)| LODIPINE (DAILY)| CELEXA (DAILY)| ALBUTEROL (DAILY)| METFORMIN (DAILY)| SIMVASTATIN (DAILY)| FLOVENT (DAILY)| SINGULAIR (DAILY)| CITRACAL D (DAILY)| MACROBID |